Nouryant garners negative CHMP opinion for Parkinson's disease
Regulatory NewsKari Oakes
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsKari OakesAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesClinical TrialsEuropePharmaceuticalsRegulatory Intelligence/Policy